You just read:

WNT Signaling Pathway Inhibitors Therapeutics Pipeline Analysis 2017: Key Players are Samumed, Can-Fite BioPharma & Tactical Therapeutics

News provided by

Research and Markets

Dec 13, 2017, 10:30 EST